These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Acute and subchronic nephrotoxicity of d-limonene in Fischer 344 rats. Webb DR; Ridder GM; Alden CL Food Chem Toxicol; 1989 Oct; 27(10):639-49. PubMed ID: 2481635 [TBL] [Abstract][Full Text] [Related]
4. Alveolar macrophage cytokine and growth factor production in a rat model of crocidolite-induced pulmonary inflammation and fibrosis. Driscoll KE; Maurer JK; Higgins J; Poynter J J Toxicol Environ Health; 1995 Oct; 46(2):155-69. PubMed ID: 7563215 [TBL] [Abstract][Full Text] [Related]
5. Effects of vanadium upon polyl:C-induced responses in rat lung and alveolar macrophages. Cohen MD; Becker S; Devlin R; Schlesinger RB; Zelikoff JT J Toxicol Environ Health; 1997 Aug; 51(6):591-608. PubMed ID: 9242230 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary surfactant obtained from starved rats enhances phagocytosis of alveolar macrophages. Sakai K; Ueyama A; Kishino Y Cell Mol Biol; 1991; 37(4):475-80. PubMed ID: 1934019 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of perillic acid in humans after a single dose administration of a citrus preparation rich in d-limonene content. Chow HH; Salazar D; Hakim IA Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1472-6. PubMed ID: 12433729 [TBL] [Abstract][Full Text] [Related]
8. The fate of dermally applied [14C]d-limonene in rats and humans. Api AM; Ritacco G; Hawkins DR Int J Toxicol; 2013; 32(2):130-5. PubMed ID: 23493903 [TBL] [Abstract][Full Text] [Related]
9. The effect of high temperature on alveolar macrophage counts in bronchoalveolar lavage fluid of F344 rats. Yamamoto S; Sato K Exp Anim; 2002 Oct; 51(5):505-8. PubMed ID: 12451712 [TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the subchronic oral toxicity of d-limonene in dogs. Webb DR; Kanerva RL; Hysell DK; Alden CL; Lehman-McKeeman LD Food Chem Toxicol; 1990 Oct; 28(10):669-75. PubMed ID: 2276695 [TBL] [Abstract][Full Text] [Related]
13. Comparison of short-term renal effects due to oral administration of decalin or d-limonene in young adult male Fischer-344 rats. Kanerva RL; Ridder GM; Lefever FR; Alden CL Food Chem Toxicol; 1987 May; 25(5):345-53. PubMed ID: 3609973 [TBL] [Abstract][Full Text] [Related]
14. Effect of orange oil on the oral absorption of enrofloxacin in rats. Lim JH; Kim MS; Hwang YH; Song IB; Kim TW; Yun HI Exp Anim; 2012; 61(1):71-5. PubMed ID: 22293675 [TBL] [Abstract][Full Text] [Related]
15. R-Limonene metabolism in humans and metabolite kinetics after oral administration. Schmidt L; Göen T Arch Toxicol; 2017 Mar; 91(3):1175-1185. PubMed ID: 27325307 [TBL] [Abstract][Full Text] [Related]
16. Oral administration of d-limonene controls inflammation in rat colitis and displays anti-inflammatory properties as diet supplementation in humans. d'Alessio PA; Ostan R; Bisson JF; Schulzke JD; Ursini MV; Béné MC Life Sci; 2013 Jul; 92(24-26):1151-6. PubMed ID: 23665426 [TBL] [Abstract][Full Text] [Related]
17. Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation. Warheit DB; Hansen JF; Yuen IS; Kelly DP; Snajdr SI; Hartsky MA Toxicol Appl Pharmacol; 1997 Jul; 145(1):10-22. PubMed ID: 9221819 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of d-limonene in the rat by GC-MS assay. Chen H; Chan KK; Budd T J Pharm Biomed Anal; 1998 Aug; 17(4-5):631-40. PubMed ID: 9682146 [TBL] [Abstract][Full Text] [Related]
19. Human metabolism of the experimental cancer therapeutic agent d-limonene. Crowell PL; Elson CE; Bailey HH; Elegbede A; Haag JD; Gould MN Cancer Chemother Pharmacol; 1994; 35(1):31-7. PubMed ID: 7987974 [TBL] [Abstract][Full Text] [Related]
20. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis. Sharma R; Saxena D; Dwivedi AK; Misra A Pharm Res; 2001 Oct; 18(10):1405-10. PubMed ID: 11697465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]